[e-drug] The 10 burning questions on the Government Use of Patent on the 4 anti-cancer drugs in Thailand

e-drug
1

E-DRUG: The 10 burning questions on the Government Use of Patent on the 4 anti-cancer drugs in Thailand
--------------------------------------------------------------------------

Dear E-druggers,

Please find "The 10 burning questions on the Government Use of
Patent on the 4 anti-cancer drugs in Thailand" at the Thai MOPH Website

http://www.moph.go.th/hot/Second_white_paper_on_the_Thai_CL_\[EN\]\.pdf

Question 1: What is the rational for the implementation
of the Government Use of Patent on the 4 anti-cancer drugs?

Question 2: Has there been any negotiation with the
patents owner before deciding to implement the
Government Use of Patent on the 4 anti-cancer drugs?

Question 3: Why does the health minister make the
decision at the time of the interim government? Can he
wait for the new minister to make the decision?

Question 4: What are the reasons for the health
minister to visit India recently? Has there been any
agreement with any Indian generic drug company on the
procurement of the generic version of the patented
drugs which may be considered as conflict of interest?

Question 5: Is it true that Thailand plan to implement
the Government Use of Patent systematically on all
patented drugs?

Question 6: How does Thailand improve the decision
processes to implement the Government Use of Patent to
make it more transparent?

Question 7: Will this decision be the reason for the
USTR to consider moving Thailand from the Priority
Watch List country to the Priority Foreign Country, if
so how is it going to affect the Thai export to the
US?

Question 8: Has there been any high level
consultation among the three concerned ministries,
i.e., health, commerce and foreign affair, to discuss
and finalize Thailand's position on the TRIPs
flexibilities according to the request from the Prime
Minister?

Question 9: How can the ministry make sure that the
drugs procured through the Government Use of Patent
will not leak out from the public non-commercial use
system to the market?

Question 10: What are the measures that can ensure
good quality generic anti-cancer drugs procured and
distributed by the Government Pharmaceutical
Organization?

Kannikar KIJTIWATCHAKUL (Kar)
Access to Essential Medicine Campaigner
MSF Belgium - Thailand Mission,
522 Mooban Nakorn Thai 14,
Ladphrao Soi 101/1,
Bangkapi, Bangkok 10240
Tel (+66) 2370 3087
Fax (+66) 2731 1432
Mobile (+66) 85-070-8954
E-mail: kakablue@yahoo.com